Application 207570
- Type
- ANDA
- Sponsor
- INVAGEN PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | AMANTADINE HYDROCHLORIDE | AMANTADINE HYDROCHLORIDE | CAPSULE;ORAL | 100MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 68996-102 | AMANTADINE HYDROCHLORIDE | AMANTADINE HYDROCHLORIDE | NewGen Pharmaceuticals LLC | ANDA | Current |
| 69097-926 | Amantadine hydrochloride | Amantadine hydrochloride | Cipla USA Inc. | ANDA | Current |
| 69844-026 | Amantadine hydrochloride | Amantadine hydrochloride | Graviti Pharmaceuticals Private Limited | ANDA | Current |